A 2018 paper jointly published by three leading infectious disease organizations (APIC, SHEA, and SIDP) stated that infection prevention and control and antibiotic stewardship programs are inextricably linked.
The farthest-along candidates are a viral vector vaccine being tested by the University of Oxford and AstraZeneca, a repurposed vaccine, originally developed in the early 1900s for protection against tuberculosis, and a whole-virus vaccine being tested by the state-owned Chinese company Sinopharm.
Companies and organizations that provide diagnostics serve an important role and must overcome many challenges inherent to developing diagnostic solutions. These areas include research and development, the regulatory environment, production and manufacturing, commercialization, and insurance and reimbursement.
Minimizing contact with others through social distancing is crucial to flatten the curve and reduce the rate of coronavirus infection. However, many people are wondering if it’s still possible to transmit the virus via food and pickup or delivery services.